Sarissa Capital Management as of Sept. 30, 2020
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 11 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biogen Idec (BIIB) | 21.5 | $182M | 643k | 283.68 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 15.6 | $132M | 928k | 142.59 | |
| Alkermes SHS (ALKS) | 15.3 | $130M | 7.8M | 16.57 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 14.9 | $126M | 14M | 8.99 | |
| Alexion Pharmaceuticals | 10.7 | $91M | 798k | 114.43 | |
| Innoviva (INVA) | 7.9 | $67M | 6.4M | 10.45 | |
| Mersana Therapeutics (MRSN) | 6.2 | $53M | 2.8M | 18.62 | |
| Intercept Pharmaceuticals In | 5.9 | $50M | 1.2M | 41.46 | |
| BioCryst Pharmaceuticals (BCRX) | 2.0 | $17M | 4.9M | 3.43 | |
| Regulus Therapeutics Com New | 0.1 | $951k | 1.9M | 0.51 | |
| Mirati Therapeutics | 0.0 | $166k | 1.0k | 166.00 |
